Axel Stenmark Tullberg

6PUBLICATIONS
26CO-AUTHORS
Predictive and prognostic markersTumour immunologyRadiation therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 05, 2025
Endothelial Cell pY397-FAK Expression Predicts the Risk of Breast Cancer Recurrences after Radiotherapy in the SweBCG91-RT Cohort.

Rebecca J G Drake, Amalia H Landén, Erik Holmberg

|Nov 07, 2023
Evaluation of tumor-infiltrating lymphocytes and mammographic density as predictors of response to neoadjuvant systemic therapy in breast cancer.

Amalia H Landén, Kian Chin, Anikó Kovács

|May 19, 2023
Combining histological grade, TILs, and the PD-1/PD-L1 pathway to identify immunogenic tumors and de-escalate radiotherapy in early breast cancer: a secondary analysis of a randomized clinical trial.

Axel Stenmark Tullberg, Martin Sjöström, Lena Tran

|Apr 18, 2023
Integrating Tumor-Intrinsic and Immunologic Factors to Identify Immunogenic Breast Cancers from a Low-Risk Cohort: Results from the Randomized SweBCG91RT Trial.

Axel Stenmark Tullberg, Martin Sjöström, Emma Niméus

|Mar 28, 2023
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial.

Moa Egelberg, Tommaso De Marchi, Gyula Pekar

|Nov 05, 2020
Immune Infiltrate in the Primary Tumor Predicts Effect of Adjuvant Radiotherapy in Breast Cancer; Results from the Randomized SweBCG91RT Trial.

Axel Stenmark Tullberg, Henri A J Puttonen, Martin Sjöström

Pageof 1

Frequent Collaborators

6 joint publications

Per Karlsson

5 joint publications

Erik Holmberg

3 joint publications

Emma Nimeús

3 joint publications

Fredrika Killander